The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success
Open accessAbstract
The marine environment harbors a number of macro and micro organisms that have developed unique metabolic abilities to ensure their survival in diverse and hostile habitats, resulting in the biosynthesis of an array of secondary metabolites with specific activities. Several of these metabolites are high-value commercial products for the pharmaceutical and cosmeceutical industries. The aim of this review is to outline the paths of marine natural products discovery and development, with a special focus on the compounds that successfully reached the market and particularly looking at the approaches tackled by the pharmaceutical and cosmetic companies that succeeded in marketing those products. The main challenges faced during marine bioactives discovery and development programs were analyzed and grouped in three categories: biodiversity (accessibility to marine resources and efficient screening), supply and technical (sustainable production of the bioactives and knowledge of the mechanism of action) and market (processes, costs, partnerships and marketing). Tips to surpass these challenges are given in order to improve the market entry success rates of highly promising marine bioactives in the current pipelines, highlighting what can be learned from the successful and unsuccessful stories that can be applied to novel and/or ongoing marine natural products discovery and development programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
A Historical Overview of Natural Products in Drug Discovery
Dias, D. A., Urban, S., & Roessner, U. (2012) · Metabolites · doi:10.3390/metabo2020303 · Cited by 1,958
Drug development from marine natural products
Molinski, T. F., Dalisay, D. S., Lievens, S. L., & Saludes, J. P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2487 · Cited by 1,186
Glycoproteins: Their composition, structure and function
Gottschalk, A. (1972) · Medical Entomology and Zoology · Cited by 862
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
Newman, D. J., & Cragg, G. M. (2004) · Journal of Natural Products · doi:10.1021/np040031y · Cited by 759
The odyssey of marine pharmaceuticals: a current pipeline perspective
Mayer, A. M. S., Glaser, K. B., Cuevas, C., Jacobs, R. S., Kem, W., Little, R. D., McIntosh, J. M., Newman, D. J., Potts, B. C., & Shuster, D. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.005 · Cited by 666
Gerwick, W. H., & Moore, B. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.014 · Cited by 601
Bioactivity and applications of sulphated polysaccharides from marine microalgae
Raposo, M., De Morais, R., & Bernardo de Morais, A. (2013) · Marine Drugs · doi:10.3390/md11010233 · Cited by 594
The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10
Pettit, G. R., Kamano, Y., Herald, C. L., Tuinman, A. A., Boettner, F. E., Kizu, H., Schmidt, J. M., Baczynskyj, L., Tomer, K. B., & Bontems, R. J. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00256a070 · Cited by 583
Metabolites from symbiotic bacteria
Piel, J. (2009) · Nat. Prod. Rep. · doi:10.1039/b703499g · Cited by 577
Strategies for discovering drugs from previously unexplored natural products
Harvey, A. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01511-7 · Cited by 542
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20112g · Cited by 518
Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation
Kingston, D. G. I. (2011) · Journal of Natural Products · doi:10.1021/np100550t · Cited by 516
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2014) · Natural Product Reports · doi:10.1039/c3np70117d · Cited by 484
Towle, M. J., Salvato, K. A., Budrow, J., Wels, B. F., Kuznetsov, G., Aalfs, K. K., Welsh, S., Zheng, W., Seletsky, B. M., Palme, M. H., et al. (2001) · PubMed · Cited by 483
Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S., & Hamann, M. T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.011 · Cited by 458
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
D'Incalci, M., & Galmarini, C. M. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0263 · Cited by 445
Marine Natural Products: A New Wave of Drugs?
Montaser, R., & Luesch, H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.118 · Cited by 437
Why Drugs Fail - A Study on Side Effects in New Chemical Entities
Schuster, D., Laggner, C., & Langer, T. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774414510 · Cited by 417 · cited 1×
“The main reasons for the withdrawals of development in clinical phases I–III are mainly due to lack of efficacy (43%) and drug toxicity (33%) [68].”
BackgroundFive Kingdoms: An Illustrated Guide to the Phyla of Life on Earth
Schmid, R., Margulis, L., & Schwartz, K. V. (1988) · Taxon · doi:10.2307/1222104 · Cited by 417
Total synthesis of halichondrin B and norhalichondrin B
Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400
Immense essence of excellence: Marine microbial bioactive compounds
Bhatnagar, I., & Kim, S.-K. (2010) · Marine Drugs · doi:10.3390/md8102673 · Cited by 384
Ziconotide for treatment of severe chronic pain
Schmidtko, A., Lötsch, J., Freynhagen, R., & Geisslinger, G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60354-6 · Cited by 356
Bio-mining the microbial treasures of the ocean: New natural products
Imhoff, J. F., Labes, A., & Wiese, J. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.03.001 · Cited by 346
Nichols, C. A. M., Guezennec, J., & Bowman, J. P. (2005) · Marine Biotechnology · doi:10.1007/s10126-004-5118-2 · Cited by 341
Natural products and combinatorial chemistry: back to the future
Ortholand, J.-Y., & Ganesan, A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.011 · Cited by 336
Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
Cuevas, C., & Francesch, A. (2009) · Natural Product Reports · doi:10.1039/b808331m · Cited by 323
Sudek, S., Lopanik, N. B., Waggoner, L. E., Hildebrand, M., Anderson, C., Liu, H., Patel, A., Sherman, D. H., & Haygood, M. G. (2007) · Journal of Natural Products · doi:10.1021/np060361d · Cited by 314
Beneficial Effects of Marine Algal Compounds in Cosmeceuticals
Thomas, N., & Kim, S.-K. (2013) · Marine Drugs · doi:10.3390/md11010146 · Cited by 302
Conus Peptides: Biodiversity-based Discovery and Exogenomics
Olivera, B. M. (2006) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84029-2 · Cited by 302
Natural Products as a Foundation for Drug Discovery
Beutler, J. A. (2009) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0911s46 · Cited by 296
Leal, M. C., Puga, J., Serôdio, J., Gomes, N. C. M., & Calado, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030580 · Cited by 294
Drugs and Cosmetics from the Sea
Kijjoa, A., & Sawangwong, P. (2004) · Marine Drugs · doi:10.3390/md202073 · Cited by 267
A review on microalgae, a versatile source for sustainable energy and materials
Satyanarayana, K. G., Mariano, A. B., & Vargas, J. V. C. (2011) · International Journal of Energy Research · doi:10.1002/er.1695 · Cited by 265
Industrial natural product chemistry for drug discovery and development
Bauer, A., & Brönstrup, M. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70058e · Cited by 255
Development of Novel Drugs from Marine Surface Associated Microorganisms
Penesyan, A., Kjelleberg, S., & Egan, S. (2010) · Marine Drugs · doi:10.3390/md8030438 · Cited by 233
Isolation and characterization of collagen from brown backed toadfish (Lagocephalus gloveri) skin
Senaratne, L. S., Park, P.-J., & Kim, S.-K. (2006) · Bioresource Technology · doi:10.1016/j.biortech.2005.02.024 · Cited by 217
Brady, S. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.195 · Cited by 211
Raguenes, G., Christen, R., Guezennec, J., Pignet, P., & Barbier, G. (1997) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-47-4-989 · Cited by 204
Suyama, T. L., Gerwick, W. H., & McPhail, K. L. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.011 · Cited by 192
Reynolds, W. F., & Enríquez, R. G. (2002) · Journal of Natural Products · doi:10.1021/np010444o · Cited by 179
High-throughput drug discovery: What can we expect from HTS?
Gribbon, P., & Andreas, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03275-1 · Cited by 174
Phospholipase A2 Inhibitors from Marine Organisms
Potts, B. C. M., Faulkner, D. J., & Jacobs, R. S. (1992) · Journal of Natural Products · doi:10.1021/np50090a001 · Cited by 168
Raguénès, G., Pignet, P., Gauthier, G., Peres, A., Christen, R., Rougeaux, H., Barbier, G., & Guézennec, J. (1996) · Applied and Environmental Microbiology · doi:10.1128/aem.62.1.67-73.1996 · Cited by 155
Radjasa, O. K., Vaske, Y. S. M., Navarro, G., Vervoort, H. C., Tenney, K., Linington, R. G., & Crews, P. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.07.017 · Cited by 147
The expanding role of marine microbes in pharmaceutical development
Waters, A. L., Hill, R. T., Place, A. R., & Hamann, M. T. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.09.013 · Cited by 145
Natural products and Pharma 2011: Strategic changes spur new opportunities
Carter, G. T. (2011) · Natural Product Reports · doi:10.1039/c1np00033k · Cited by 144
Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer
Schumacher, M., Kelkel, M., Dicato, M., & Diederich, M. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.02.002 · Cited by 138
Eccles, R., Meier, C., Jawad, M., Weinmüllner, R., Grassauer, A., & Prieschl‐Grassauer, E. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-108 · Cited by 136
A renaissance in marine pharmacology: From preclinical curiosity to clinical reality
Glaser, K. B., & Mayer, A. M. S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.015 · Cited by 134
Pettit, R. K. (2010) · Marine Biotechnology · doi:10.1007/s10126-010-9294-y · Cited by 131
Lichtman, M. A. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.10.005 · Cited by 125
Kim, Y. H., Chung, C. B., Jin Guk, K. I. M., Ko, K. I., Park, S. H., Kim, J., Eom, S., Kim, Y. S., Hwang, Y.-I., & Kim, K. (2008) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70268 · Cited by 111
Structure, function and immunochemistry of bacterial exopolysaccharides
Weiner, R., Langille, S. E., & Quintero, E. J. (1995) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/bf01569989 · Cited by 108
Coral aquaculture to support drug discovery
Leal, M. C., Calado, R., Sheridan, C., Alimonti, A., & Osinga, R. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.06.004 · Cited by 107
Vincent, P., Pignet, P., Talmont, F., Bozzi, L., Fournet, B., Guézennec, J., Jeanthon, C., & Prieur, D. (1994) · Applied and Environmental Microbiology · doi:10.1128/aem.60.11.4134-4141.1994 · Cited by 104
Cambon‐Bonavita, M., Raguénès, G., Jean, J. D., Vincent, P., & Guézennec, J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2002.01689.x · Cited by 94
Michel, T., Halabalaki, M., & Skaltsounis, A. (2013) · Planta Medica · doi:10.1055/s-0032-1328300 · Cited by 94
NAPROC-13: a database for the dereplication of natural product mixtures in bioassay-guided protocols
López‐Pérez, J. L., Therón, R., del Olmo, E., & Díaz, D. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm516 · Cited by 93
The impact of the United Nations Convention on Biological Diversity on natural products research
Cragg, G. M. L., Katz, F. N., Newman, D. J., & Rosenthal, J. (2012) · Natural Product Reports · doi:10.1039/c2np20091k · Cited by 80
Structural data on a bacterial exopolysaccharide produced by a deep-sea Alteromonas macleodii strain
Costaouëc, T. L., Cérantola, S., Ropartz, D., et al. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.04.059 · Cited by 79
Costello, M., Bouchet, P., Emblow, C., & Legakis, A. (2006) · Marine Ecology Progress Series · doi:10.3354/meps316257 · Cited by 78
Combinatorial biosynthesis in plants: A (p)review on its potential and future exploitation
Pollier, J., Moses, T., & Goossens, A. (2011) · Natural Product Reports · doi:10.1039/c1np00049g · Cited by 76
Leal, M. C., Madeira, C., Brandão, C., Puga, J., & Calado, R. (2012) · Molecules · doi:10.3390/molecules17089842 · Cited by 75
Pre-fractionated Microbial Samples – The Second Generation Natural Products Library at Wyeth
Wagenaar, M. M. (2008) · Molecules · doi:10.3390/molecules13061406 · Cited by 73
DNA assembly techniques for next-generation combinatorial biosynthesis of natural products
Cobb, R. E., Ning, J. C., & Zhao, H. (2013) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-013-1358-3 · Cited by 71
Antiviral agents from a gorgonian,Eunicella cavolini
Cimino, G. G., Rosa, S. D., & Stefano, S. D. (1984) · Cellular and Molecular Life Sciences · doi:10.1007/bf01952539 · Cited by 69
ω-Conotoxin MVIIA: From Marine Snail Venom to Analgesic Drug
Olivera, B. M. (2000) · KARGER eBooks · doi:10.1159/000062483 · Cited by 64
Petersen, F., & Amstutz, R. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8595-8 · Cited by 56
SCIENCE/TECHNOLOGY: Supply Issues Complicate Trek Of Chemicals From Sea To Market
ROUHI, A. M. (1995) · Chemical & Engineering News · doi:10.1021/cen-v073n047.p042 · Cited by 49
Leeds, J. A., Schmitt, E. K., & Krastel, P. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.3.211 · Cited by 44
Is coarse taxonomy sufficient for detecting macroinvertebrate patterns in floodplain lakes?
Jiang, X., Xiong, J., Song, Z., Morse, J. C., Jones, F. C., & Xie, Z. (2012) · Ecological Indicators · doi:10.1016/j.ecolind.2012.11.015 · Cited by 34
Monk, B. J., Dalton, H., Benjamin, I., & Tanovı́c, A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802002814 · Cited by 33
Rupp, H. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0045-2 · Cited by 30
Omega-3-acid Ethyl Esters (Lovaza) For Severe Hypertriglyceridemia
Koski, R. R. (2008) · PubMed Central · Cited by 26
Martins, A., Tenreiro, T., Andrade, G., Gadanho, M., Chaves, S., Abrantes, M., Calado, P., Tenreiro, R. P., & Vieira, H. (2013) · Marine Drugs · doi:10.3390/md11051506 · Cited by 20
Self-citationDay, D. R., Jabaiah, S., Jacobs, R. S., & Little, R. D. (2013) · Marine Drugs · doi:10.3390/md11093258 · Cited by 18
Glueck, C. J., Khan, N., Riaz, M., Padda, J., Khan, Z., & Wang, P. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-143 · Cited by 16
Beyond the HapMap Genotypic Data: Prospects of Deep Resequencing Projects
Zhang, W., & Dolan, M. (2008) · Current Bioinformatics · doi:10.2174/157489308785909232 · Cited by 15
Combinatorial biosynthesis in symbiotic bacteria
Piel, J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio1206-661 · Cited by 14
Cited by
Exploring the ocean for new drug developments: Marine pharmacology
Malve, H. (2016) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.171700 · Cited by 420
Karthikeyan, A., Joseph, A., & Nair, B. G. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00290-4 · Cited by 336
Fernandes, A., Rodrigues, P. M., Pintado, M., & Tavaria, F. K. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154824 · Cited by 264
M. U., N., Mehar, J. G., Mudliar, S. N., & Shekh, A. Y. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12500 · Cited by 236
Farghali, M., Mohamed, I. M. A., Osman, A. I., & Rooney, D. W. (2023) · Environmental Chemistry Letters · doi:10.1007/s10311-022-01520-y · Cited by 225
Metadata
- Authors
- Martins, A., Vieira, H., Gaspar, H., & Santos, S.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2014-02-17
- Volume
- 12
- Issue
- 2
- Pages
- 1066-1101
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W2139857335
- Cited by
- 572
- References
- 86
- FWCI
- 33.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.